超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

日本 衛材,Eisai,  
日本衛材株式會社是一家以研究開發醫藥產品為主的跨國公司，總部設在日本東京，始建于1941年，其海外分支機構、子公司和工廠分布于歐洲、美洲和亞洲各地。作為一家立足于科研的醫藥公司，我們十分重視產品研發工作。以筑波研究所為協調中心，大約有1300名研究者在全球晝夜不停的工作，開發下一代有創造性的新藥，滿足亟待解決的醫學需求。我們致力于神經病學、胃腸病學以及腫瘤學專業領域的研究。為了涉足未來的專業領域，我們還在不斷把研究拓展到新興的前沿學科。

衛材（中國）藥業有限公司是由衛材株式會社全額投資成立的獨資制藥企業。衛材株式會社是一家以研究開發醫藥產品為主的跨國公司，總部設在日本東京。衛材自90年代初進入中國市場以來順利發展至今。在沈陽成立了沈陽衛材制藥有限公司，隨后在蘇州工業園區成立了制藥工廠衛材（蘇州）制藥有限公司，也就是現在衛材（中國）藥業有限公司的前身。并于2002年起更名為衛材（中國）藥業有限公司。目前公司在中國銷售的藥品多達十余種，主要集中在中樞神經系統，消化領域，內分泌和骨科領域。

Eisai Co., Ltd. Japan is a multinational pharmaceutical company with strong R&D capabilities. It was founded in 1941, with the headquarters located in Tokyo. Since its foundation, the Company has actively expanded into overseas markets and now has sales subsidiaries and factories in America, Europe and Asia. As a research-based pharmaceutical company ,we give high priority to research and development activities. With Tsukuba Research Laboratories serving as a coordinating center, approximately 1300 researchers globally work around the clock to develop next-generation and innovative new drugs to satisfy unmet medical needs. Our research is focused on areas of expertise in neurology and gastrointestinal diseases, as well as oncology. We are also expanding research into new frontier areas in order to establish future specialty fields.

Eisai China Inc. is a pharmaceutical company solely invested by Eisai Co., Ltd. Japan, a multinational pharmaceutical company. Eisai has been developing smoothly in China since the early 1990s. It went through Shenyang Eisai and Eisai Suzhou successively (a Japan-funded company, located in Suzhou industrial Park), and later it was renamed as Eisai China Inc. since 2002.